Urine lateral flow lipoarabinomannan assay for diagnosing active tuberculosis in adults living with HIV

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Shah, Maunank ^a   Hanrahan, Colleen ^b   Wang, Zhuo Yu ^c   Steingart, Karen R ^d   Lawn, Stephen D ^e   Denkinger, Claudia ^f   Dendukuri, Nandini ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PROTOCOL; DATA COLLECTION METHOD; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOASSAY; LUNG TUBERCULOSIS; POINT OF CARE TESTING; PRIORITY JOURNAL; PROCESS DESIGN; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TUBERCULOSIS; URINE LATERAL FLOW LIPOARABINOMANNAN ASSAY;

EID: 84961614432     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011420     Document Type: Article

References (39)

1. TM TB LAM Ag Product Information. http://www.alere.com/ww/en/product-details/determine-tb-lam.html (accessed 16 Nov 2014).
2. Bartlett JG. Tuberculosis and HIV infection: partners in human tragedy. Journal of Infectious Diseases 2007;196(Suppl 1):S124-5.
3. Batz HG, Cooke GS, Reid SD. Towards lab-free tuberculosis diagnosis. http://www.msfaccess.org/content/towards-lab-free-tuberculosis-diagnosis. London: Imperial College, (accessed 16 Nov 2014).
4. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. New England Journal of Medicine 2010;362(8):707-16.
5. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine 2003;163(9):1009-21.
6. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 2010;5(3):e9848.
7. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007;369(9578):2042-9.
8. Getahun H, Gunneberg C, Granich R, Nunn P. HIV Infection - associated tuberculosis: the epidemiology and the response. Clinical Infectious Diseases 2010;50(Suppl 3):S201-7.
9. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Medicine 2011;8(1):e1000391.
10. Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. Journal of the American Medical Association 2008;300(4):423-30.
11. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clinical Microbiology Reviews 2011;24(2):351-76.
12. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 2009;23(14):1875-80.
13. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infectious Diseases 2012;12:103.
14. Lawn SD, KerkhoffAD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infectious Diseases 2012;12(3):201-9.
15. Lawn SD, Dheda K, KerkhoffAD, Peter JG, Dorman S, Boehme CC, et al. Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infectious Diseases 2013;13:407.
16. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing 2000;10:325-37.
17. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available from http://srdta.cochrane.org/. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter%2010%20-%20Version%201.0.pdf.
18. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. European Respiratory Journal 2011;38(6):1398-1405.
19. Pai NP, Pai M. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Discovery Medicine 2012;13(68):35-45.
20. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. Journal of Infectious Diseases 2007;196(Suppl 1):S15-27.
21. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Current Opinion of Pulmonary Medicine 2010;16(3):262-70.
22. Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, et al. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. European Respiratory Journal 2012;40(5):1211-20.
23. R Development Core Team. R: A language and environment for statistical computing. 2.15.1. Vienna: R Foundation for Statistical Computing, 2008.
24. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90.
25. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
26. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, et al. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. Journal of Acquired Immune Deficiency Syndrome 2009;52(2):145-51.
27. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infectious Diseases 2003;3(5):288-96.
28. StataCorp. Stata Statistical Software. 13. Texas: StataCorp LP, 2011.
29. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infectious Diseases 2006;6(9):570-81.
30. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD009593.pub3]
31. TB CARE I. International Standards for Tuberculosis Care, Edition 3. TB Care 1, The Hague. http://www.who.int/tb/publications/ISTC_3rdEd.pdf?ua=1 (accessed 16 Nov 2014):1-87.
32. Weyer K, Carai S, Nunn P. Viewpoint TB diagnostics: what does the world really need?. Journal of Infectious Diseases 2011;204(Suppl 4):S1196-202.
33. Whalen C, Horsburgh CR, Hom D, Lahart C, SimberkoffM, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. American Journal of Respiratory and Critical Care Medicine 1995;151(1):129-35.
34. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36.
35. World Health Organization. Global tuberculosis control: WHO report 2013. WHO/HTM/TB/2013.11. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf. Geneva: World Health Organization, (accessed 16 Nov 2014):1-289.
36. World Health Organization. HIV-associated TB facts. http://www.who.int/tb/challenges/hiv/tbhiv_factsheet_2013.pdf (accessed 16 Nov 2014).
37. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. WHO/HTM/TB/2013.16. http://apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf. Geneva: WHO, (accessed 16 Nov 2014).
38. World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. WHO/HTM/TB/2013.04. http://www.who.int/tb/publications/Final_TB_Screening_guidelines.pdf (accessed 16 Nov 2014).
39. World Bank. World Bank List of Economies (February 2014). Washington (District of Columbia): World Bank, 2014.